These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 13136252)

  • 1. L-Triiodothyronine versus L-thyroxine: a comparison of their metabolic effects in human myxedema.
    RAWSON RW; RALL JE; PEARSON OH; ROBBINS J; POPPELL HF; WEST CD
    Trans Assoc Am Physicians; 1953; 66():86-94; discussion, 94-6. PubMed ID: 13136252
    [No Abstract]   [Full Text] [Related]  

  • 2. 1-Triiodothyronine versus 1-throxine; a comparison of their metabolic effects in human myxedema.
    RAWSON RV; RALL JE; PEARSON OH; ROBBINS J; POPPELL HF; WEST CD
    Am J Med Sci; 1953 Oct; 226(4):405-11. PubMed ID: 13092101
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the rate of protein synthesis before and during the administration of L-triiodothyronine to patients with myxedema and healthy volunteers using N-15 glycine.
    CRISPELL KR; PARSON W; HOLLIFIELD G
    J Clin Invest; 1956 Feb; 35(2):164-9. PubMed ID: 13286335
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metabolism of triiodothyronine in hyperthyroidism and in myxedema].
    Zaninovich AA; Degrossi O; Pecorini V
    Medicina (B Aires); 1970; 30(4):380-3. PubMed ID: 5487694
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic studies in myxedema following administration of 1-triiodothyronine: 1) duration of negative nitrogen balance; 2) effect of testosterone propionate; 3) comparison with nitrogen balance in a healthy volunteer.
    CRISPELL KR; HOLLIFIELD G; PARSON W; WILLIAMS GA
    J Clin Endocrinol Metab; 1957 Feb; 17(2):221-31. PubMed ID: 13398461
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic effects of intravenous triiodothyroacetic acid in primary myxedema.
    DE GRAEFF J; QUERIDO A; WICHT CL
    J Clin Endocrinol Metab; 1957 Feb; 17(2):328-30. PubMed ID: 13398475
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of triiodothyronine & thyroxin in primary myxedema; comparative investigation].
    FRIIS T; IVERSEN K
    Ugeskr Laeger; 1957 Nov; 119(48):1548-51. PubMed ID: 13530302
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relationship between triiodothyronine kinetics and metabolic changes. II].
    Zaninovich A; Degrossi O; Pecorini V; Gotta H
    Medicina (B Aires); 1969; 29(4):259-62. PubMed ID: 5382839
    [No Abstract]   [Full Text] [Related]  

  • 9. Calorigenic effects of single intravenous doses of L-triiodothyronine and L-thyroxine in myxedematous persons.
    BLACKBURN CM; McCONAHEY WM; KEATING FR; ALBERT A
    J Clin Invest; 1954 Jun; 33(6):819-24. PubMed ID: 13163173
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serotonin metabolism disorders during early myxedema].
    Kliachko VR; Stoilov LD; Shapiro GA
    Vopr Med Khim; 1968; 14(6):577-80. PubMed ID: 5733696
    [No Abstract]   [Full Text] [Related]  

  • 11. [Radiochromatographic analysis of the subhepatic and peripheral blood, of the bile and urine, at successive stages after administration of labeled 3,5,3-triiodo-L-thyronine to an athyroid myxedematous patient].
    TURPIN R; ROCHE J; TRITTO C; MICHEL R; CRUVEILLER J
    Rev Fr Etud Clin Biol; 1960 May; 5():485-90. PubMed ID: 13839986
    [No Abstract]   [Full Text] [Related]  

  • 12. [Congenital hypothyroidism & myxedema, treated with triiodothyronine, with special reference to the ECG].
    LANGANKE E
    Munch Med Wochenschr; 1957 Mar; 99(13):454-5. PubMed ID: 13430688
    [No Abstract]   [Full Text] [Related]  

  • 13. Myxedema heart disease. Case of massive pericardial effusion with dramatic response to L-triiodothyronine.
    HARRIS R; ARAVANIS C
    Exp Med Surg; 1960; 18():47-58. PubMed ID: 13711780
    [No Abstract]   [Full Text] [Related]  

  • 14. The physiologic activity of l-triiodothyronine.
    LERMAN J
    J Clin Endocrinol Metab; 1953 Nov; 13(11):1341-6. PubMed ID: 13108954
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of myxedema with l-triiodothyronine].
    HIGUERA J; DURAN I; SALVATIERRA D
    Rev Clin Esp; 1958 Sep; 70(6):361-5. PubMed ID: 13624220
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiocirculatory and electrocardiographic modifications in myxedema of the adult treated with L-triiodothyronine].
    Benedetti A; Cattano G
    G Clin Med; 1965 Jul; 46(7):521-48. PubMed ID: 5864753
    [No Abstract]   [Full Text] [Related]  

  • 17. Myxedema coma.
    Kwaku MP; Burman KD
    J Intensive Care Med; 2007; 22(4):224-31. PubMed ID: 17712058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [L-thyroxin sodium in therapy of myxedema].
    LUND E
    Nord Med; 1954 Jun; 51(26):880-1. PubMed ID: 13176763
    [No Abstract]   [Full Text] [Related]  

  • 19. Body fluids and electrolyte balance in myxedema.
    SOFFER LJ; IANNACCONE A; WIENER R; GRIBOFF SI; EISENBERG J
    Acta Endocrinol (Copenh); 1954; 17(1-4):418-25. PubMed ID: 13227854
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic use of triiodothyronine in myxedema].
    KLIACHKO VR; TSLAF ZZ
    Ter Arkh; 1963 Mar; 35():112-6. PubMed ID: 14033482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.